Company intelligence / Profile preview

Young Blood Institute

Stanford, California, United States

Ownership: Private
Employees: ~1
Development stage: Other

Overview

Young Blood Institute is a 501(c)(3) non-profit clinical research organization studying use of therapeutic plasma exchange (TPE) and heterochronic plasma exchange as a preventive immunotherapy for age-associated diseases, applying a well-established apheresis procedure (plasmapheresis) to aging and autoimmunity–like conditions under an IRB‑approved clinical research protocol.[1][4] No pivotal randomized controlled outcome data or approved commercial products are reported; activities are positioned as research using established TPE technology rather than development of a new drug.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Non-pharmacological therapy
Industry: Academic Hospital/University/Research

Beyond the preview

Go deeper on Young Blood Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Young Blood Institute.

Explore the full profile